Circulatory microRNA-145 expression is increased in cerebral ischemia
Related Experiment Video
Updated: May 24, 2026

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
1Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. mr.dennisgan@gmail.com
Abstract:
Cerebral ischemia or ischemic stroke is mainly attributed to vascular and circulation disorders. Among protein biomarkers, RNA profiles have also been identified as markers of ischemic stroke. MicroRNA-145 expression is ostensibly recognized as marker and modulator of vascular smooth muscle cell phenotype; however, expression levels in ischemic stroke had not been investigated. Employing real-time quantitative PCR, we examined the expression profile of circulatory microRNA-145 in healthy control subjects (N = 14) and ischemic stroke patients (N = 32). Circulatory microRNA-145 expression was significantly higher in ischemic stroke patients than in control subjects. This demonstrates that hemostatic mechanisms are affected by ischemic stroke. We conclude that circulating microRNA-145 has potential as a biomarker for ischemic stroke.
Insights
Circulating microRNA-145 levels are significantly elevated in patients with ischemic stroke compared to healthy individuals. This finding suggests microRNA-145 may serve as a novel biomarker for stroke diagnosis and understanding hemostatic alterations.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Cerebral ischemia, or ischemic stroke, primarily stems from vascular and circulation issues.
- While protein biomarkers are known, RNA profiles, including microRNAs, are emerging as potential stroke markers.
- MicroRNA-145 (miR-145) is recognized for its role in vascular smooth muscle cell phenotype, but its expression in ischemic stroke was unexamined.
Purpose of the Study:
- To investigate the expression levels of circulatory microRNA-145 in patients with ischemic stroke.
- To determine if microRNA-145 can serve as a biomarker for ischemic stroke.
Main Methods:
- Real-time quantitative PCR was used to analyze circulatory microRNA-145 expression.
- The study included 32 ischemic stroke patients and 14 healthy control subjects.
Main Results:
- Circulatory microRNA-145 expression was significantly higher in ischemic stroke patients compared to healthy controls.
- The elevated levels indicate that hemostatic mechanisms are impacted by ischemic stroke.
Conclusions:
- Circulating microRNA-145 shows potential as a diagnostic biomarker for ischemic stroke.
- Further research is warranted to explore the role of miR-145 in stroke pathophysiology and hemostasis.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction